Mechanisms of Hepatic and Renal Toxicity in Long-Term Animal Models
The liver and kidneys are primary sites of xenobiotic metabolism and clearance, making them common targets in preclinical toxicity studies. Understanding the mechanistic basis of hepatic and renal injury in chronic and subchronic animal models is critical for interpreting toxicological data and assessing human relevance. Hepatotoxicity may result from reactive metabolite formation, mitochondrial dysfunction, bile acid accumulation, or oxidative stress. Histopathologic findings often include hepatocellular hypertrophy, steatosis, cholestasis, or necrosis, accompanied by serum biomarker elevations such as ALT, AST, and bilirubin.
Renal toxicity mechanisms include proximal tubular cell injury, glomerular damage, and interstitial fibrosis. These changes are commonly linked to impaired filtration, accumulation of nephrotoxic metabolites, or interference with transporters such as OATs and OCTs. Histologically, nephrotoxicity may present as tubular degeneration, cast formation, and inflammatory infiltrates, often reflected in elevated serum creatinine and BUN.
Evaluating these findings in long-term studies requires consideration of dose-response trends, progression over time, and reversibility. Advanced techniques such as immunohistochemistry, electron microscopy, and transcriptomics can provide further mechanistic insight and aid in distinguishing adaptive versus adverse responses. These mechanistic interpretations are crucial in regulatory discussions and influence risk assessments, clinical monitoring parameters, and decisions on compound advancement.